Search Results 111-120 of 17845 for monoclonal antibody
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...
... monoclonal antibody) in subjects with relapsed or refractory Multiple Myeloma. Participation eligibility. Participant eligibility includes age, gender, type ...
About this study. The purpose of this study is to investigate whether clazakizumab (an anti-interleukin (IL)-6 monoclonal antibody (mAb)) may be beneficial ...
It helps the immune system destroy cancer cells. Rituximab injection is a monoclonal antibody. Rituximab injection is used together with other medicines (eg, ...
Immunotherapy with monoclonal antibodies ... Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called ...
Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Giving nivolumab before nephrectomy may make the ...
The purpose of this study is to evaluate the safety and tolerability of the combination of idelallisib with the monoclonal antibody BI 836826 for the treatment ...
Monoclonal antibodies, such as pembrolizumab, may ... Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2.
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Giving imiquimod and pembrolizumab may work ...
The purpose of this study is to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!